Vir Biotechnology is an immunology company that creates products to treat serious infectious diseases, including COVID-19, hepatitis B, influenza A, and HIV. The company has established collaborations with various institutions, including the Bill & Melinda Gates Foundation and GlaxoSmithKline Biologicals SA. Vir Biotechnology is based in San Francisco and was founded in 2016.